Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 6370-6377

  Yang, Yiping ^a   Su, Qin ^a   Grewal, Iqbal S ^b   Schilz, Robert ^b   Flavell, Richard A ^b   Wilson, James M ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; GENE THERAPY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029817036     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.6370-6377.1996     Document Type: Article

References (33)

1. Allen, R., R. Armitage, M. Conley, H. Rosenblatt, N. Jenkins, N. Copeland, M. Bedell, S. Edelhoff, C. Disteche, D. Simonequx, W. Fanslow, J. Belmont, and M. Spriggs. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990-993.
2. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. Grosmaire, R. Stenkamp, and M. Neubauer. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291-300.
3. Dai, Y., E. M. Schwarz, D. Gu, W. Zhang, N. Sarvetnick, and I. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
4. Disanto, J., J. Bonnefoy, J. Gauchel, A. Fischer, and G. deSainte Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (London) 361:541-543.
5. Durie, F. H., R. A. Fava, T. M. Foy, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-1330.
6. Durie, F. H., T. M. Foy, S. R. Masters, J. D. Laman, and R. J. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406-411.
7. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196-6200.
8. Fang, B., R. Eisensmith, H. Wang, M. Kay, R. Cross, C. Landen, G. Gordon, D. Bellinger, M. Read, P. Hu, K. Brinkhous, and S. Woo. 1995. Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum. Gene Ther. 6:1039-1044.
9. Foy, T., J. Laman, J. Ledbetter, A. Aruffo, E. Claassen, and R. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157-163.
10. Grewal, I., J. Xu, and R. Flavell. 1995. Impairment of antigenspecific T-cell priming in mice lacking CD40 ligand. Nature (London) 378:617-619.
11. Jenkins, M. K. 1994. The ups and downs of T cell costimulation. Immunity 1:443-446.
12. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimotot, and H, Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178.
13. Kay, M., A. Holterman, L. Meuse, A. Gown, H. Ochs, P. Linsley, and C. Wilson. 1995. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat. Genet. 11:191-197.
14. Korthauer, U., D. Graf, H. Mages, F. Briere, M. Padayachee, S. Malcolm, A. Ugazio, L. Notarangelo, R. Levinsky, and R. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (London) 361:539-541.
15. Kozarsky, K. F., D. R. McKinley, L. L. Austin, S. E. Raper, L. D. Stratford-Perricaudet, and J. M. Wilson. 1994. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable with recombinant adenoviruses. J. Biol. Chem. 269:1-8.
16. Li, Q., M. A. Kay, M. Finegold, L. D. Stratford-Perricaudet, and S. L. C. Woo. 1993. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4:403-409.
17. Renshaw, B., W. Fanslow, R. Armitage, K. Campbell, D. Liggitt, B. Wright, B. Davison, and C. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
18. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet, M. Perricaudet, W. B. Guggino, A. Pavirani, J. P. Lecocq, and R. G. Crystal. 1992. In vivo transfer of the human cystic fibrosis transmem-brane conductance regulator gene to the airway epithelium. Cell 68:143-155.
19. Stout, R., J. Suttles, J. Xu, I. Grewal, and R. Flavell. 1996. Impaired T cell-mediated macrophage activation in CD40 ligand deficient mice. J. Immunol. 156:8-11.
20. Tivol, E., F. Borriello, A. Schweitzer, W. Lynch, J. Bluestone, and A. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547.
21. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature (London) 378:620-623.
22. Van Ginkel, F., C. Liu, J. Simecka, J. Dong, T. Greenway, R. Frizzell, H. Kiyono, J. McGhee, and D. Pascual. 1995. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Hum. Gene Ther. 6:895-903.
23. Waterhouse, P., J. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. Lee, C. Thompson, H. Griesser, and T. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985-988.
24. Xu, J., T. Foy, J. Laman, E. Elliott, J. Dunn, T. Waldschmidt, J. Elsemore, R. Noelle, and R. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423-431.
25. Yang, Y., H. C. J. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1:433-442.
26. Yang, Y., K. Greenough, and J. M. Wilson. 1996. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3:412-420.
27. Yang, Y., Q. Li, H. Ertl, and J. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
28. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
29. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. E. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy for cystic fibrosis. Nat. Genet. 7:362-369.
30. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1:890-893.
31. Yang, Y., Z. Xiang, H. C. J. Ertl, and J. M. Wilson. 1995. Upregulation of class I MHC antigens by interferon-γ is necessary for the T cell-mediated elimination of recombinant adenovirus infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257-7261.
32. Yei, S., N. Mittereder, K. Tang, C. O'Sullivan, and B. C. Trapnell. 1994. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1:192-200.
33. Zsengeller, Z., S. Wert, W. Hull, X. Hu, S. Yei, B. Trapnell, and J. Whitsett. 1995. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6:457-467.